Long-acting formulations, monoclonal antibodies and non-opioid therapies aim to improve adherence, curb misuse and reduce relapse, supported by government initiativesDublin, Oct. (GLOBE NEWSWIRE) -- ...
Asianet Newsable on MSN
AI risks slower, poorer business decisions despite fast analysis: report
A McKinsey report warns companies risk slower, poorer strategic decisions despite using AI. While AI speeds up analysis, human judgment lags, as executives struggle to review the growing volume of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results